Patent foramen ovale closure, antiplatelet therapy or anticoagulation therapy alone for management of cryptogenic stroke? A clinical practice guideline

Ton Kuijpers; Frederick A. Spencer; Reed A.C. Siemieniuk; Per O. Vandvik; Catherine M. Otto; Lyubov Lytvyn; Hassan Mir; Albert Y. Jin; Veena Manja; Ganesan Karthikeyan; Elke Hoendermis; Janet Martin; Sebastian Carballo; Martin O'Donnell; Trond Vartdal; Christine Baxter; Bray Patrick-Lake; Joanie Scott; Thomas Agoritsas; Gordon Guyatt

doi:10.1136/bmj.k2515

Patent foramen ovale closure, antiplatelet therapy or anticoagulation therapy alone for management of cryptogenic stroke? A clinical practice guideline

Ton Kuijpers, Frederick A. Spencer, Reed A.C. Siemieniuk, Per O. Vandvik, Catherine M. Otto, Lyubov Lytvyn, Hassan Mir, Albert Y. Jin, Veena Manja, Ganesan Karthikeyan, Elke Hoendermis, Janet Martin, Sebastian Carballo, Martin O'Donnell, Trond Vartdal, Christine Baxter, Bray Patrick-Lake, Joanie Scott, Thomas Agoritsas, Gordon Guyatt

UC Davis

Research output: Contribution to journal › Article › peer-review

53 Scopus citations

Original language	English (US)
Article number	k2515
Journal	BMJ (Online)
Volume	362
DOIs	https://doi.org/10.1136/bmj.k2515
State	Published - Jan 1 2018

ASJC Scopus subject areas

Medicine(all)

Access to Document

10.1136/bmj.k2515

Cite this

Kuijpers, T., Spencer, F. A., Siemieniuk, R. A. C., Vandvik, P. O., Otto, C. M., Lytvyn, L., Mir, H., Jin, A. Y., Manja, V., Karthikeyan, G., Hoendermis, E., Martin, J., Carballo, S., O'Donnell, M., Vartdal, T., Baxter, C., Patrick-Lake, B., Scott, J., Agoritsas, T., & Guyatt, G. (2018). Patent foramen ovale closure, antiplatelet therapy or anticoagulation therapy alone for management of cryptogenic stroke? A clinical practice guideline. BMJ (Online), 362, [k2515]. https://doi.org/10.1136/bmj.k2515

Patent foramen ovale closure, antiplatelet therapy or anticoagulation therapy alone for management of cryptogenic stroke? A clinical practice guideline. / Kuijpers, Ton; Spencer, Frederick A.; Siemieniuk, Reed A.C.; Vandvik, Per O.; Otto, Catherine M.; Lytvyn, Lyubov; Mir, Hassan; Jin, Albert Y.; Manja, Veena; Karthikeyan, Ganesan; Hoendermis, Elke; Martin, Janet; Carballo, Sebastian; O'Donnell, Martin; Vartdal, Trond; Baxter, Christine; Patrick-Lake, Bray; Scott, Joanie; Agoritsas, Thomas; Guyatt, Gordon.

In: BMJ (Online), Vol. 362, k2515, 01.01.2018.

Research output: Contribution to journal › Article › peer-review

Kuijpers, T, Spencer, FA, Siemieniuk, RAC, Vandvik, PO, Otto, CM, Lytvyn, L, Mir, H, Jin, AY, Manja, V, Karthikeyan, G, Hoendermis, E, Martin, J, Carballo, S, O'Donnell, M, Vartdal, T, Baxter, C, Patrick-Lake, B, Scott, J, Agoritsas, T & Guyatt, G 2018, 'Patent foramen ovale closure, antiplatelet therapy or anticoagulation therapy alone for management of cryptogenic stroke? A clinical practice guideline', BMJ (Online), vol. 362, k2515. https://doi.org/10.1136/bmj.k2515

Kuijpers, Ton ; Spencer, Frederick A. ; Siemieniuk, Reed A.C. ; Vandvik, Per O. ; Otto, Catherine M. ; Lytvyn, Lyubov ; Mir, Hassan ; Jin, Albert Y. ; Manja, Veena ; Karthikeyan, Ganesan ; Hoendermis, Elke ; Martin, Janet ; Carballo, Sebastian ; O'Donnell, Martin ; Vartdal, Trond ; Baxter, Christine ; Patrick-Lake, Bray ; Scott, Joanie ; Agoritsas, Thomas ; Guyatt, Gordon. / Patent foramen ovale closure, antiplatelet therapy or anticoagulation therapy alone for management of cryptogenic stroke? A clinical practice guideline. In: BMJ (Online). 2018 ; Vol. 362.

@article{22a89e58af0d487dbe56eb5a4719dbc1,

title = "Patent foramen ovale closure, antiplatelet therapy or anticoagulation therapy alone for management of cryptogenic stroke? A clinical practice guideline",

author = "Ton Kuijpers and Spencer, {Frederick A.} and Siemieniuk, {Reed A.C.} and Vandvik, {Per O.} and Otto, {Catherine M.} and Lyubov Lytvyn and Hassan Mir and Jin, {Albert Y.} and Veena Manja and Ganesan Karthikeyan and Elke Hoendermis and Janet Martin and Sebastian Carballo and Martin O'Donnell and Trond Vartdal and Christine Baxter and Bray Patrick-Lake and Joanie Scott and Thomas Agoritsas and Gordon Guyatt",

year = "2018",

month = jan,

day = "1",

doi = "10.1136/bmj.k2515",

language = "English (US)",

volume = "362",

journal = "The BMJ",

issn = "0959-8146",

publisher = "BMJ Publishing Group",

}

TY - JOUR

T1 - Patent foramen ovale closure, antiplatelet therapy or anticoagulation therapy alone for management of cryptogenic stroke? A clinical practice guideline

AU - Kuijpers, Ton

AU - Spencer, Frederick A.

AU - Siemieniuk, Reed A.C.

AU - Vandvik, Per O.

AU - Otto, Catherine M.

AU - Lytvyn, Lyubov

AU - Mir, Hassan

AU - Jin, Albert Y.

AU - Manja, Veena

AU - Karthikeyan, Ganesan

AU - Hoendermis, Elke

AU - Martin, Janet

AU - Carballo, Sebastian

AU - O'Donnell, Martin

AU - Vartdal, Trond

AU - Baxter, Christine

AU - Patrick-Lake, Bray

AU - Scott, Joanie

AU - Agoritsas, Thomas

AU - Guyatt, Gordon

PY - 2018/1/1

Y1 - 2018/1/1

UR - http://www.scopus.com/inward/record.url?scp=85050817838&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85050817838&partnerID=8YFLogxK

U2 - 10.1136/bmj.k2515

DO - 10.1136/bmj.k2515

M3 - Article

C2 - 30045912

AN - SCOPUS:85050817838

VL - 362

JO - The BMJ

JF - The BMJ

SN - 0959-8146

M1 - k2515

ER -

Patent foramen ovale closure, antiplatelet therapy or anticoagulation therapy alone for management of cryptogenic stroke? A clinical practice guideline

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this